KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 126 filers reported holding KALA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $74,750 | -22.8% | 11,025 | -14.6% | 0.00% | -50.0% |
| Q3 2020 | $96,825 | -29.0% | 12,910 | -0.5% | 0.00% | 0.0% |
| Q2 2020 | $136,367 | +79.6% | 12,975 | +50.2% | 0.00% | 0.0% |
| Q1 2020 | $75,910 | -99.9% | 8,636 | +63.5% | 0.00% | +100.0% |
| Q1 2018 | $83,630,000 | +32314.7% | 5,283 | -53.3% | 0.00% | -50.0% |
| Q3 2017 | $258,000 | – | 11,314 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 1 | $9 | 0.00% |